Background
Methods
Papers included in the analysis
Statistical analysis
SAM by MUAC but not by WHZ criteria – designated as “S-muac”
SAM by WHZ but not by MUAC criteria – designated as “S-whz”
SAM by both MUAC and WHZ criteria – designated as “S-both”
Meta-analyses
Effect of including or excluding “S-both” in the analyses
Ethical statement
Results
Ref | Study | Author & year | Country | Settinga | Study design | Prospect Retrosp | Date of data | MUAC stand | WHZ stand | Age range | Oed | Oed cases | “Both” in study | “Both” in survey | Time obs | Missing data | Default or lost | Original analysis |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# | # | year | mm | Z or % | month | % | % | % | d.m | % | % | |||||||
Studies giving numbers of children fulfilling both WHZ and MUAC criteria | ||||||||||||||||||
41 | 1 | Aguayo 2015 | India | IPF | Case notes | Retrosp | 2009–11 | < 115 | <− 3 WHO | 6–59 | excl | 63.9 | 21.3 | 14 d | ng | 22.9 | Log reg | |
42 | 2 | Grellety 2012 | Niger | Com | Com trial | Prospect | 2010 | < 115 | <−3 WHO |
6–23
| excl | 35.1 | 24.9 | 5 m | 5.3 | 0.0 | Cox PH reg | |
21 | 3 | Grellety 2015 | South Sudan | OTP | Case notes | Retrosp | 2008 | < 115 | <−3 WHO | 6–59 | excl | 31.7 | 20.3 | 51 d | 8.6 | 15.0 | Binom reg | |
43 | 4 | Isanaka 2015 | Niger | OTP | RCT | Prospect | 2012–3 | < 115 | <−3 WHO | 6–59 | excl | 39.2 | 24.9 | 29.5 d | 0.0 | 1.0 | Log-binom | |
44 | 5 | Lowlaavar 2016 | Uganda | IPF | Cohort | Prospect | 2012–3 | < 115 | <−3 WHO | 6–60 | excl | 22.5 | 11.6 | 3 d | ng | 9.7 | Log reg | |
45 | 6 | LaCourse 2014 | Malawi | IPF | Case notes | Prospect | 2011–2 |
< 110
| < 70% NCHS | 6–60 | excl | 14.2 | 8.8 | ng | 0.5 | 0.0 | Chisq OR | |
35 | 7 | Olofin 2016 | DRC,Senegal,Nepal | Com | Com cohort | Prospect | 1983–92 | < 115 | <−3 WHO | 6–59 | excl | 21.9 | 20,12,7 | 2–6 m | ng | ng | Cox PH reg | |
Studies including oedema | ||||||||||||||||||
46 | 8 | Berkley 2005 | Kenya | IPF | Case notes | Prospect | 1999–02 | < 115 | <−3 NCHS |
12–59
| incl | 34.2 | 42.9 | 8.8b | ng | 3.6 | ng | ROC curve |
47 | 9 | Chiabi 2017 | Cameroun | IPF | Case notes | Retrosp | 2006–14 | < 115 | <− 3 WHO | 6–59 | incl | ng | 58.5 | 17.0 | ng | 30.7 | 10.1 | ROC curve |
48 | 10 | Sachdeva 2016 | India | IPF | Case notes | Prospect | 2012–3 | < 115 | <−3 WHO | 6–60 | incl | 3.8 | 32.2 | 21.3 | 3.7 d | ng | 15.0 | ROC curve |
Studies where children fulfilling both criteria are incorporated into both the WHZ and MUAC categories | ||||||||||||||||||
49 | 11 | Burza 2016 | India | Com | Follow up | Prospect | 2009–11 | < 115 | <−3 WHO | 6–59 | ng | ng | ng | 21.3 | 18 m | 26.7 | ng | Log reg |
50 | 12 | Mogeni 2011 | Kenya | IPF | Case notes | Prospect | 2007–9 | < 115 | <−3 WHO | 6–60 | incl | 19.2 | ng | 8.8b | ng | 5.4 | ng | Chisq |
51 | 13 | Sylla 2015 | Senegal | IPF | Case notes | Retrosp | 2012 | < 115 | <− 3 WHO |
0–60
| ng | ng | ng | 6.6 | ng | ng | ng | Log reg |
52 | 14 | Vella 1990 | Uganda | Com | Com cohort | Prospect | 1988 | < 115 | <−3 NCHS |
0–60
| incl | ng | ng | 11.6 | ng | 13.0 | 10.0 | Log reg |
53 | 15 | Dramaix 1993 | DRC | IPF | Case notes | Prospect | 1986–8 | < 115 | < 70% NCHS | 0–60 | incl | 28.9 | ng | 11.5 | 60 d | 15.4 | ng | Log reg |
54 | 16 | Girum 2017 | Ethiopia | IPF | Case notes | Retrosp | 2013–5 | < 115 |
< 70% ng
| ng | incl | 66.6 | ng | 15.5 | 13 d | ng | 11.6 | Cox PH reg |
55 | 17 | Savadogo 2007 | BFA | IPF | Case notes | Retrosp | 1999–03 |
Tertile
|
<−3 NCHS
| 0- < 36 | excl | ng | ng | 18.3 | 19 d | ng | 18.3 | Cox PH reg |
36 | 18 | Garenne1987 | Senegal | Com | Com cohort | Prospect | 1983–4 | < 115 | <−3 NCHS |
1–60
| incl | ng | ng | 6.6 | 3 m | ng | ng | Life table |
37 | 19 | Garenne 2009 | Senegal | Com | Com cohort | Prospect | 1983–4 |
< 110
|
CDC2000
|
1–60
| incl | ng | ng | 6.6 | 3 m | ng | ng | Life table |
37 | 20 | Garenne 2009 | DRC | Com | Com cohort | Prospect | 1989–92 |
< 110
|
CDC2000
|
1–60
| incl | ng | ng | 11.5 | 6 m | ng | ng | Life table |
38 | 21 | VD Broeck 1993 | DRC | Com | Com cohort | Prospect | 1989–92 |
<−4 SD
| <−3 NCHS |
0–60
| incl | ng | ng | 11.5 | 3 m | ng | ng | Life table |
Ref | Study | Author & year | Kwash | Total SAM | S-whz | S-muac | S-both |
S-whz
|
S-muac
|
S-both
| WHZ v MUAC | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | dead | Total | dead | Total | dead | Total | dead | Total | dead |
CFR
|
CFR
|
CFR
| χ2 | χ2 | Fisher | Cramer | |||
# |
#
| # | # | # | # | # | # | # | # | # | # |
%
|
%
|
%
| value | p (2-tail) | p (1-tail) | V | |
Studies giving numbers of children fulfilling both WHZ and MUAC criteria | |||||||||||||||||||
41 | 1 | Aguayo 2015 | 231 | 11 | 6076 | 32 | 1333 | 3 | 859 | 2 | 3884 | 27 |
0.23
|
0.23
|
0.70
| 0.65 | 0.00 | ||
42 | 2 | Grellety 2012 | 2 | 0 | 530 | 13 | 177 | 3 | 167 | 2 | 186 | 8 |
1.69
|
1.20
|
4.30
| 0.53 | 0.02 | ||
21 | 3 | Grellety 2015 | excl | excl | 2205 | 40 | 1486 | 13 | 21 | 1 | 698 | 26 |
0.87
|
4.76
|
3.72
| 0.22 | 0.12 | ||
43 | 4 | Isanaka 2015 | excl | excl | 2399 | 13 | 530 | 3 | 929 | 4 | 940 | 6 |
0.57
|
0.43
|
0.64
| 0.48 | 0.03 | ||
44 | 5 | Lowlaavar 2016 | excl | excl | 262 | 21 | 171 | 11 | 32 | 0 | 59 | 10 |
6.43
|
0.00
|
16.95
| 0.14 | 0.10 | ||
45 | 6 | LaCourse 2014 | 97 | 8 | 210 | 15 | 29 | 2 | 68 | 4 | 16 | 1 |
6.90
|
5.88
|
6.25
| 0.58 | 0.02 | ||
35 | 7 | Olofin 2016 | ng | ng | 767 | 145 | 116 | 18 | 483 | 64 | 168 | 63 |
15.50
|
13.25
|
37.50
| 0.41 | 0.52 | 0.31 | 0.03 |
Studies including oedema | |||||||||||||||||||
46 | 8 | Berkley 2005 | 390 | ng | 1140 | 193 | 267 | 27 | 384 | 42 | 489 | 124 |
10.11
|
10.94
|
25.36
| 0.11 | 0.74 | 0.42 | 0.01 |
47 | 9 | Chiabi 2017 | ng | ng | 106 | 22 | 23 | 1 | 21 | 3 | 62 | 18 |
4.35
|
14.29
|
29.03
| 0.27 | 0.17 | ||
48 | 10 | Sachdeva 2016 | ng | ng | 447 | 59 | 228 | 18 | 75 | 15 | 144 | 26 |
7.89
|
20.00
|
18.06
| 8.52 |
0.004
|
0.004
| 0.17 |
Studies where children fulfilling both criteria are incorporated into both the WHZ and MUAC categories | |||||||||||||||||||
All-whz | All-muac |
All-whz
|
All-muac
| All-whz v All-muac | |||||||||||||||
49 | 11 | Burza 2016 | ng | ng | 650 | 36 | 295 | 26 | 650 | 36 |
8.81
|
5.54
| 3.55 | 0.06 |
0.042
| 0.06 | |||
50 | 12 | Mogeni 2011 | 392 | ng | 1768 | 217 | 966 | 101 | 802 | 116 |
10.46
|
14.46
| 6.54 |
0.011
| 0.06 | ||||
51 | 13 | Sylla 2015 | ng | ng | 272 | 42 | 90 | 27 | 117 | 15 |
30.00
|
12.82
| 9.28 |
0.002
|
0.002
| 0.21 | |||
52 | 14 | Vella 1990 | ng | ng | 118 | 22 | 34 | 3 | 96 | 18 |
8.82
|
18.75
| 0.14 | 0.12 | |||||
53 | 15 | Dramaix 1993 | 320 | 102 | 442 | 122 | 267 | 63 | 175 | 57 |
23.60
|
32.57
| 4.31 |
0.038
|
0.025
| 0.10 | |||
54 | 16 | Girum 2017 | 363 | 25 | 545 | 51 | 130 | 26 | 277 | 41 |
20.00
|
14.80
| 1.74 | 0.19 | 0.12 | 0.07 | |||
55 | 17 | Savadogo 2007 | excl | excl | 1322 | 212 | 930 | 168 | 387 | 95 |
18.03
|
24.50
| 7.19 |
0.007
| 0.01 | ||||
36 | 18 | Garenne1987 | ng | ng | 622 | 63 | 92 | 14 | 569 | 54 |
15.22
|
9.49
| 2.81 | 0.09 | 0.06 | 0.07 | |||
37 | 19 | Garenne 2009 | ng | ng | 281 | 44 | 183 | 23 | 98 | 21 |
12.57
|
21.43
| 3.79 | 0.051 |
0.040
| 0.12 | |||
37 | 20 | Garenne 2009 | ng | ng | 388 | 25 | 150 | 9 | 238 | 16 |
6.00
|
6.72
| 0.08 | 0.78 | 0.48 | 0.01 | |||
38 | 21 | Broeck 1993 | 56 | 8 | 652 | 13 | 113 | 3 | 539 | 6 |
2.65
|
1.11
| 0.14 | 0.05 |
The effect of oedema
Effect of the reference criteria
Effect of mode of treatment
Overall analysis
Grouping of deficits
Study | Author & year | Single deficits alone | Single and both deficits | Difference WHZ-MUAC | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S-whz
|
S-muac
| S-whz v S-muac | All-whz | All-muac | All-whz v All-muac | S-whz-S-muac | All-whz-All-muac | Effect on CFR | ||||||
CFR
|
CFR
| χ2 | Fisher | Cramer | CFR | CFR | χ2 | Fisher | Cramer | |||||
%
|
%
|
p
|
p
| % | % | p | p | |||||||
1 | Aguayo 2015 | 0.23 | 0.23 |
nc
| (0.96) | 0.00 | 0.58 | 0.61 | 0.81 | nc | 0.00 | −0.01 | −0.04 | >All |
2 | Grellety 2012 | 1.69 | 1.20 |
nc
| 0.73 | 0.02 | 3.03 | 2.83 | 0.88 | 0.880 | 0.01 | 0.50 | 0.20 | >S |
3 | Grellety 2015 | 0.87 | 4.76 |
nc
| (0.19) | 0.05 | 1.79 | 3.76 | 0.002 | nc | 0.06 | −3.89 | −1.97 | >S |
4 | Isanaka 2015 | 0.57 | 0.43 |
nc
| (0.68) | 0.01 | 0.61 | 0.54 | 0.77 | nc | 0.01 | 0.14 | 0.08 | >S |
5 | Lowlaavar 2016 | 6.43 | 0.00 |
nc
| 0.14 | 0.10 | 9.13 | 10.99 | 0.61 | 0.607 | 0.03 | 6.43 | −1.86 | Reverse |
6 | LaCourse 2014 | 6.90 | 5.88 |
nc
| 0.83 | 0.02 | 6.67 | 5.95 | nc | 0.860 | 0.01 | 1.01 | 0.71 | >S |
7 | Olofin 2016 | 15.52 | 13.25 | 0.52 | 0.52 | 0.03 | 28.52 | 19.51 | 0.002 | nc | 0.10 | 2.27 | 9.01 | >All |
8 | Berkley 2005 | 10.11 | 10.94 | 0.74 | 0.74 | 0.01 | 19.97 | 19.01 | 0.63 | nc | 0.01 | −0.83 | 0.96 | Reverse |
9 | Chiabi 2017 | 4.35 | 14.29 |
nc
| 0.31 | 0.17 | 22.35 | 25.30 | 0.65 | 0.659 | 0.03 | −9.94 | −2.95 | >S |
10 | Sachdeva 2016 | 7.89 | 20.00 |
0.004
|
0.005
| 0.17 | 11.83 | 18.72 |
0.021
|
0.023
| 0.09 | −12.11 | −6.89 | >S |